🔎 Trials Near Me

Beranda › Gangguan Depresi Mayor › Florida › Orlando

Uji klinis Gangguan Depresi Mayor di Orlando, FL

19 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi sekitar Orlando (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Menerima pesertaFase 3
  • Nova Psychiatry INC, Orlando
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Menerima pesertaFase 3
  • Accel Research Sites - Maitland, Maitland · 6 mi jauhnya
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Menerima pesertaFase 2
  • Seaport Investigator Site, Orlando
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Menerima pesertaFase 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Menerima pesertaFase 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Menerima pesertaFase 2
  • Draig Clinical Site, Orlando
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07300969

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Menerima pesertaFase 3
  • Clinical Neuroscience Solutions, LLC (Orlando), Orlando
  • Charter Research, Orlando
  • K2 Medical Research (Maitland), Maitland · 6 mi jauhnya
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Menerima pesertaFase 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Menerima pesertaFase 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06547489

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Orlando
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi jauhnya
  • Neurocrine Clinical Site, Maitland · 6 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Menerima pesertaFase 2
  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Menerima pesertaFase 3
  • Neurocrine Clinical Site, Maitland · 6 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Menerima peserta
  • AdventHealth Neuroscience Institute, Orlando
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 22 Okt 2025 · NCT05877885

Study of ALTO-300 in MDD

Menerima pesertaFase 2
  • Site 159, Clermont · 24 mi jauhnya
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Menerima pesertaFase 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jan 2025 · NCT06223880

Uji klinis Gangguan Depresi Mayor di kota lain

Studi lain di Orlando

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.